Given that Sig-1R agonists could decrease ERS and protect neuronal structure and function in several neurodegenerative diseases, there might be a possible connection existed between Sig-1R-regulated ERS and C3 production. This evidence concerns the gene SIGMAR1 and neurodegenerative disease.